Renalytix plc Quarterly Operating Income (Loss) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Renalytix plc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
  • Renalytix plc Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.09M, a 54% increase year-over-year.
  • Renalytix plc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.8M, a 37% increase year-over-year.
  • Renalytix plc annual Operating Income (Loss) for 2024 was -$29.6M, a 29.9% increase from 2023.
  • Renalytix plc annual Operating Income (Loss) for 2023 was -$42.2M, a 20.6% increase from 2022.
  • Renalytix plc annual Operating Income (Loss) for 2022 was -$53.2M, a 66.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$24.8M -$4.09M +$4.8M +54% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$29.6M -$5.53M +$4.41M +44.4% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 -$34M -$6.55M +$4.36M +40% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$38.4M -$8.64M +$1.01M +10.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$39.4M -$8.89M +$2.83M +24.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$42.2M -$9.93M +$3.12M +23.9% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$45.3M -$10.9M +$3.62M +24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$49M -$9.65M +$4.13M +30% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$53.1M -$11.7M +$92K +0.78% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$53.2M -$13.1M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 -$14.5M -$6.47M -80.1% Jan 1, 2022 Mar 31, 2022 6-K 2023-06-09
Q4 2021 -$13.8M -$5.17M -60% Oct 1, 2021 Dec 31, 2021 6-K 2023-03-30
Q3 2021 -$11.8M Jul 1, 2021 Sep 30, 2021 6-K 2022-11-30
Q1 2021 -$8.07M Jan 1, 2021 Mar 31, 2021 6-K 2022-06-30
Q4 2020 -$8.61M Oct 1, 2020 Dec 31, 2020 6-K/A 2022-04-29
Q2 2018 -$567K Mar 15, 2018 Jun 30, 2018 20-F/A 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.